4//SEC Filing
Sjuts Dustin S 4
Accession 0001479290-22-000105
CIK 0001479290other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:11 PM ET
Size
5.0 KB
Accession
0001479290-22-000105
Insider Transaction Report
Form 4
Sjuts Dustin S
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2022-12-15$21.50/sh−2,916$62,694→ 95,207 total
Footnotes (1)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on December 15, 2022, to satisfy tax withholding obligations that arose in connection with the vesting of Restricted Stock award (the "RSA") for 11,973 shares. The RSA vests in three equal annual installments from December 15, 2021, subject to Mr. Sjuts' Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001796224
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:11 PM ET
- Size
- 5.0 KB